Member Info for Ronnycant

... was pre-clinical data.. Read the RNS

This is just a logical rerate... No need to speculate and break momentum when it does not materialize.

... you have chemo on steroids with reduced side effects... That's why after downsizing my position lately, I have bought back my original position.

I have been wondering about that. If they give the same dose indeed, and little goes to waste in cells that are in the rest of the human body, more dox will be going around to attach to the actual tumor cells... But maybe it is not that simple. Maybe it gets secreted out via the kidneys?
Either way, if your theory is inline with reality, it would be a massive deal.. Less chemo required, way less toxicity and significant increase in efficacy.

Hello? Anyone home? Wake me up when they submit...

I might have to reshuffle and buy some more...

I am reading confusing messages on the daily FCF for PMG. Dutch TTF pricing at 53EUR... Is this the price for a BOE? Or is that closer to a 100USD per BOE? Opex is about 9.9EUR(or USD?) per BOE... And that on about 800 BOE/day...

Thanks in advance for any clarification/correction...

is taking longer than I expected... Maybe I had the wrong expectations... Did I underestimate the cellulose topic?

At the end of the article it states:
"The study was funded by the Wellcome Trust, the Medical Research Council, the Technology Strategy Board and Avacta and is published today (30 June 2021) in the journal, Nature Communications."

So since it is partially funded by AVACTA, I presume they have at least partial rights to it.

Wrong... that is in case all 10.000 people would be infected...

It is a decent test, and it is solde for about 4EUR / test. I'd say...96.3% vs 98%... is not a world of difference in my eyes.

I must be overlooking something, but where exactly is #avct beating @NanoReproAG with the antigen test?
https://www.m-medientechnik24.de/out/media/CPSR_Evaluation_NanoRepro_SARS-Cov-2%20Ag_Schnelltest_v02_MM24.pdf

That 150.000 was me :-) Maybe I was a bit trigger happy setting my limit... but this top-up should do well in the coming months. Fingers crossed

I presume there is simply not enough trade-volume in combination with a seller who can only get rid of his shares slooooowly... meaning... plenty of time for future top-ups

He is paid to read out loud the questions that Al paid him for...

Trading halted for over an hour... I wonder why

50 dollars profit? Per BOE? That seems a bit steep unless I missed something

No...

Key Question? Are there currently tests for sale on the market that are all of the below:
- antigen
- anterior nasal swab
- LFT-format
- Results in 5-10min
- above 90%/95% S/S
- price around/below 10GBP
- mass scaleable
If not, then #AVCT is still "go" for a blockbuster-sale.

Well,
Some investors just decided that "participation in the upcoming tender" is the next cliff (to fall off). If only that was the only tender for the testing, I would agree... This however is just one of many tenders to come next year, so I wouldn't be so "dramatic".
Nevertheless, investing is a self-fulfilling prophecy, so I am 100% sure that due to this expectation by some, not being part of the upcoming tender will result in a drop of the shareprice.
I am probably delusional, but I will hold.